YU JOHN S (CEO and Chairman) received a stock award from KAIROS PHARMA, LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/26/2025ACC: 0001493152-25-025197
DirectorOfficer10% Owner· CEO and Chairman
Since Sep 2024
+190.84K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
190.84K acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+190.84K
Price / share
—
Trade value
—
% of position
486.0%
10/8/2025
39.27K→230.10K
Total
Net shares
+190.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 10/8/2025 | A · Award | +190.84K | — | — | 486.0% | 39.27K | 230.10K |
| Total | +190.84K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
COMMON STOCK
IndirectShares owned5.32M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| COMMON STOCK | 5.32M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported